Rwanda is emerging as a regional biotechnology hub through investments in mRNA vaccine manufacturing, regulatory systems, scientific workforce development, and international partnerships, including BioNTech, the African Union/Africa CDC Partnerships for African Vaccine Manufacturing, and the Team Europe Initiative on Manufacturing and Access to Vaccines, Medicines and Health Technologies (MAV+). Complementing manufacturing capacity, the Rwanda Food and Drugs Authority’s attainment of WHO Maturity Level 3 represents an important advancement in regulatory oversight and quality assurance. Investments in biotechnology, bio-manufacturing, regulatory science, biomedical engineering, and quality-control training further strengthen the human-capital foundation required for sustainable local production.

The presentation evaluates how these interconnected initiatives can reduce supply-chain dependency, accelerate technology transfer, and enhance equitable access to essential health technologies. Persistent challenges—including infrastructure gaps, financing, technology transfer, workforce capacity, and regulatory harmonisation—are critically examined. Rwanda’s experience provides a relevant model for advancing sustainable pharmaceutical manufacturing, regional health security, and greater medical self-reliance across Africa.

About the Speaker

Professor Leon Mutesa is an MD, PhD, and serves as the Director of the Center for Human Genetics at the College of Medicine and Health Sciences, University of Rwanda, a center he established in 2006. He obtained his MD from the University of Rwanda in 2003 and earned his PhD in 2009 from the University of Liege, Belgium, where he also completed his postdoc in 2011. Significant involvement in academics, clinical genetic research, genomics, and epigenomics, as well as building research capacity, have all been hallmarks of his career. He has held several prestigious positions in the health sector in Rwanda. A pioneering figure in the field of genetics and genomics, Professor Mutesa has spearheaded the development and implementation of Rwanda’s reference center for human genetics, the only facility of its kind in East Africa. He is the Principal Investigator of several research grants funded by NIH, EU, EDCTP, NIHR, Wellcome Trust among others. He is a research pioneer of the transgenerational
epigenomics of trauma and PTSD in Rwanda, a research programme focusing on the transgenerational transmission of the epigenomic impact of genocide exposure and PTSD in women survivors and their offspring of the 1994 genocide against the Tutsi. He has supervised over 100 MSc, MMed, PhD, and Post-Doc fellows from Rwanda and from overseas universities. With more than 230 peer-reviewed publications to his name, he is a prolific contributor to scientific research. His outstanding contributions to human genetics have been recognized with the prestigious HUGO African Prize 2024 and he is a Fellow of African Academy of Sciences (FAA). He is currently serving as a board member of the Board of Trustees of the International Vaccine Institute (IVI).

LinkedIn: https://www.linkedin.com/in/leon-mutesa-8837487a/?originalSubdomain=rw
Wikipedia Page: https://en.m.wikipedia.org/wiki/Leon_Mutesa